Fund style shifts: pharmaceutical-themed funds top quarterly performance rankings.

Recently, the style of funds has been switching faster than expected. As the third quarter draws to a close, pharmaceutical funds, which had been dormant for nearly half a year, have made a strong comeback, shifting from also-rans to front-runners. After AI, optical modules, semiconductors, gas turbines, and other hard-tech sectors dominated the market's main line for two consecutive quarters, the latest quarterly return rankings may reveal a new signal: the pharmaceutical sector, which was once reduced to an also-ran during the tech rally in the first half of the year, is returning to the public fund industry's spotlight from the margins of the market. Among actively managed equity funds, the top 15 gainers over the past three months are all pharmaceutical-themed funds.